1. Home
  2. HTCR vs ALLR Comparison

HTCR vs ALLR Comparison

Compare HTCR & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTCR
  • ALLR
  • Stock Information
  • Founded
  • HTCR 2009
  • ALLR 2004
  • Country
  • HTCR Japan
  • ALLR United States
  • Employees
  • HTCR N/A
  • ALLR N/A
  • Industry
  • HTCR EDP Services
  • ALLR Biotechnology: Pharmaceutical Preparations
  • Sector
  • HTCR Technology
  • ALLR Health Care
  • Exchange
  • HTCR Nasdaq
  • ALLR Nasdaq
  • Market Cap
  • HTCR 16.9M
  • ALLR 15.8M
  • IPO Year
  • HTCR 2022
  • ALLR N/A
  • Fundamental
  • Price
  • HTCR $0.96
  • ALLR $1.66
  • Analyst Decision
  • HTCR
  • ALLR Strong Buy
  • Analyst Count
  • HTCR 0
  • ALLR 1
  • Target Price
  • HTCR N/A
  • ALLR $9.00
  • AVG Volume (30 Days)
  • HTCR 2.4M
  • ALLR 21.5M
  • Earning Date
  • HTCR 08-13-2025
  • ALLR 08-15-2025
  • Dividend Yield
  • HTCR N/A
  • ALLR N/A
  • EPS Growth
  • HTCR N/A
  • ALLR N/A
  • EPS
  • HTCR N/A
  • ALLR N/A
  • Revenue
  • HTCR $29,625,381.00
  • ALLR N/A
  • Revenue This Year
  • HTCR N/A
  • ALLR N/A
  • Revenue Next Year
  • HTCR $3.52
  • ALLR N/A
  • P/E Ratio
  • HTCR N/A
  • ALLR N/A
  • Revenue Growth
  • HTCR 72.95
  • ALLR N/A
  • 52 Week Low
  • HTCR $0.39
  • ALLR $0.61
  • 52 Week High
  • HTCR $3.38
  • ALLR $3.91
  • Technical
  • Relative Strength Index (RSI)
  • HTCR 55.00
  • ALLR 59.12
  • Support Level
  • HTCR $0.84
  • ALLR $1.78
  • Resistance Level
  • HTCR $1.15
  • ALLR $1.92
  • Average True Range (ATR)
  • HTCR 0.23
  • ALLR 0.25
  • MACD
  • HTCR -0.02
  • ALLR 0.02
  • Stochastic Oscillator
  • HTCR 24.20
  • ALLR 52.25

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

Share on Social Networks: